EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Volume 217 / Numéro 3-4 (2023) Biologie Aujourd’hui, 217 3-4 (2023) 157-160 References
Free Access
Issue
Biologie Aujourd’hui
Volume 217, Number 3-4, 2023
Page(s) 157 - 160
DOI https://doi.org/10.1051/jbio/2023029
Published online 29 novembre 2023
  • Angst, J., Angst, F., Gerber-Werder, R., Gamma, A. (2005). Suicide in 406 mood-disorder patients with and without long-term medication: A 40 to 44 years’ follow-up. Arch Suicide Res, 9, 279-300. [CrossRef] [PubMed] [Google Scholar]
  • Ballard, E.D., Wills, K., Lally, N., Richards, E.M., Luckenbaugh, D.A., Walls, T., Ameli, R., Niciu, M.J., Brutsche, N.E., Park, L., Zarate, C.A. (2017). Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. J Affect Disord, 218, 195-200. [CrossRef] [PubMed] [Google Scholar]
  • Bryleva, E.Y., Brundin, L. (2017). Kynurenine pathway metabolites and suicidality. Neuropharmacology, 112, 324-330. [CrossRef] [PubMed] [Google Scholar]
  • Chen, M., Lin, W., Wu, H., Cheng, C., Li, C., Hong, C. (2019) Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD). J Affect Disord, 251, 162-169. [CrossRef] [PubMed] [Google Scholar]
  • Ducasse, D., Olié, E., Guillaume, S., Artéro, S., Courtet, P. (2015). A meta-analysis of cytokines in suicidal behavior. Brain Behav Immun, 46, 203-211. [CrossRef] [PubMed] [Google Scholar]
  • Ducasse, D., Loas, G., Dassa, D., Gramaglia, C., Zeppegno, P., Guillaume, S., Olié, E., Courtet, P. (2018). Anhedonia is associated with suicidal ideation independently of depression: A meta-analysis. Depress Anxiety, 35, 382-392. [CrossRef] [MathSciNet] [Google Scholar]
  • Duman, R.S., Shinohara, R., Fogaça, M.V., Hare, B. (2019). Neurobiology of rapid-acting antidepressants: Convergent effects on GluA1-synaptic function. Mol Psychiatry, 24, 1816-1832 [CrossRef] [PubMed] [Google Scholar]
  • Dwivedi, Y., Brain-derived neurotrophic factor in suicide pathophysiology, in: Y. Dwivedi (Ed.), The neurobiological basis of suicide, CRC Press/Taylor & Francis, 2012. [CrossRef] [Google Scholar]
  • Evans, J.W., Szczepanik, J., Brutsché, N., Park, L.T., Nugent, A.C., Zarate, C.A. (2018). Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration. Biol Psychiatry, 84, 582-590. [CrossRef] [PubMed] [Google Scholar]
  • Franklin, J.C., Ribeiro, J.D., Fox, K.R., Bentley, K.H., Kleiman, E.M., Huang, X., Musacchio, K.M., Jaroszewski, A.C., Chang, B.P., Nock, M.K. (2017). Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research. Psychol Bull, 143, 187-232. [CrossRef] [PubMed] [Google Scholar]
  • Grunebaum, M., Ellis, S., Keilp, J., Moitra, V., Cooper, T., Marver, J.A., Milak, M.E., Oquendo, M., Mann, J. (2017). Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial. Bipolar Disord, 19, 176-183. [CrossRef] [PubMed] [Google Scholar]
  • Hong, C.-J., Liou, Y.-J., Tsai, S.-J. (2011). Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull, 86, 287-297. [CrossRef] [PubMed] [Google Scholar]
  • Lally, N., Nugent, A.C., Luckenbaugh, D.A., Ameli, R., Roiser, J.P., Zarate, C.A. (2014). Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Transl Psychiatry, 4, e469. [CrossRef] [PubMed] [Google Scholar]
  • Nobile, B., Ramoz, N., Jaussent, I., Gorwood, P., Olié, E., Castroman, J.L., Guillaume, S., Courtet, P. (2019). Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients. Sci Rep, 9, 2569. [CrossRef] [PubMed] [Google Scholar]
  • Nobile, B., Lutz, P.-E., Olié, E., Courtet, P. (2020). The role of opiates in social pain and suicidal behavior. Curr Top Behav Neurosci, 46, 197-210. [CrossRef] [PubMed] [Google Scholar]
  • Nobile, B., Dubois, J., Aouizerate, B., Aubin, V., Loftus, J., Bellivier, F., Belzeaux, R., Dubertret, C., Gard, S., Haffen, E., Schwan, R., Llorca, P.-M., Passerieux, C., Roux, P., Polosan, M., Etain, B., Leboyer, M., FondaMental Advanced Centres of Expertise in Bipolar Disorders (FACE-BD) Collaborators, Courtet, P., Olié, E. (2021). Characterization of depressed bipolar patients with current suicidal ideation. ANZJP, 55, 289-304. [Google Scholar]
  • Nobile, B., Olié, E., Dubois, J., Benramdane, M., Guillaume, S., Courtet, P. (2022). Characterization of suicidal depression: A 1 year prospective study. Eur Psychiatry, 65, e24. [CrossRef] [PubMed] [Google Scholar]
  • Oquendo, M.A., Baca-Garcia, E. (2014). Suicidal behavior disorder as a diagnostic entity in the DSM-5 classification system: Advantages outweigh limitations. World Psychiatry, 13, 128-130. [CrossRef] [PubMed] [Google Scholar]
  • Saito, K., Nowak, T.S., Markey, S.P., Heyes, M.P. (1993). Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J Neurochem, 60, 180-192. [CrossRef] [PubMed] [Google Scholar]
  • Schmaal, L., van Harmelen, A.-L., Chatzi, V., Lippard, E.T.C., Toenders, Y.J., Averill, L.A., Mazure, C.M., Blumberg, H.P. (2020). Imaging suicidal thoughts and behaviors: A comprehensive review of 2 decades of neuroimaging studies. Mol Psychiatry, 25, 408-427. [CrossRef] [PubMed] [Google Scholar]
  • Smith, K.A., Cipriani, A. (2017). Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disord, 19, 575-586. [CrossRef] [PubMed] [Google Scholar]
  • Wilkinson, S.T., Ballard, E.D., Bloch, M.H., Mathew, S.J., Murrough, J.W., Feder, A., Sos, P., Wang, G., Zarate, C.A., Sanacora, G. (2018). The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data meta-analysis. Am J Psychiatry, 175, 150-158. [CrossRef] [PubMed] [Google Scholar]
  • Williams, N.R., Heifets, B.D., Bentzley, B.S., Blasey, C., Sudheimer, K.D., Hawkins, J., Lyons, D.M., Schatzberg, A.F. (2019). Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism. Mol Psychiatry, 24, 1779-1786. [CrossRef] [PubMed] [Google Scholar]
  • Witt, K., Potts, J., Hubers, A., Grunebaum, M.F., Murrough, J.W., Loo, C., Cipriani, A., Hawton, K. (2020). Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. ANZJP, 54, 29-45. [Google Scholar]
  • Zhou, Y.-L., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., Chen, L., Li, M., Ning, Y. (2018). Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression. Brain Behav Immun, 74, 205-212. [Google Scholar]
  • Zhou, Y.-L., Wu, F.-C., Wang, C.-Y., Zheng, W., Lan, X.-F., Deng, X.-R., Ning, Y.-P. (2020). Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder. J Affect Disord, 276, 608-615. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.